AMED:NSD-Amedisys Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 96.63

Change

0.00 (0.00)%

Market Cap

USD 3.16B

Volume

0.27M

Analyst Target

USD 253.14
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Address: 3854 American Way, Baton Rouge, LA, United States, 70816

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

N/A

USD 8.62B
ACHC Acadia Healthcare Company Inc

N/A

USD 5.88B
OPCH Option Care Health Inc

N/A

USD 5.37B
SGRY Surgery Partners Inc

N/A

USD 4.06B
LFST Lifestance Health Group Inc

N/A

USD 2.66B
ASTH Astrana Health Inc

N/A

USD 2.58B
ADUS Addus HomeCare Corporation

N/A

USD 2.37B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 1.00B
HCSG Healthcare Services Group Inc

N/A

USD 0.81B
CMPS Compass Pathways Plc

N/A

USD 0.50B

ETFs Containing AMED

MARB First Trust Vivaldi Merge.. 4.83 % 0.00 %

N/A

USD 0.03B
OLD 0.00 % 0.50 %

N/A

N/A
RWM ProShares Short Russell20.. 0.00 % 0.95 %

N/A

USD 0.15B
SRTY ProShares UltraPro Short .. 0.00 % 0.95 %

N/A

USD 0.08B
TWM ProShares UltraShort Russ.. 0.00 % 0.95 %

N/A

USD 0.05B
TZA Direxion Daily Small Cap .. 0.00 % 0.95 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.76% 50% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.76% 50% F 27% F
Trailing 12 Months  
Capital Gain -22.41% 44% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.41% 44% F 27% F
Trailing 5 Years  
Capital Gain -44.68% 20% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -44.68% 20% F 26% F
Average Annual (5 Year Horizon)  
Capital Gain -7.51% N/A N/A 28% F
Dividend Return -7.51% N/A N/A 27% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 39.49% N/A N/A 46% F
Risk Adjusted Return -19.01% N/A N/A 29% F
Market Capitalization 3.16B 83% B 84% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector